Japan Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2025-2033

Description

Japan precision medicine market size reached USD 4,855 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,374 Million by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The increasing demand for telemedicine and remote monitoring technologies, which allow for continuous data collection and analysis, thereby enabling healthcare providers to make real-time adjustments to treatment plans based on individual patient data, is primarily driving the market.

Precision medicine refers to an innovative healthcare approach that tailors medical treatment and interventions to individual patients based on their unique environmental, genetic, and lifestyle factors. Unlike traditional one-size-fits-all approaches, precision medicine recognizes that each person's genetic makeup and life circumstances are distinct. By analyzing a person's genetic profile and other relevant data, healthcare providers can make more accurate diagnoses, predict disease risk, and personalize treatment plans. This approach allows for treatments that are not only more effective but also potentially safer, as they minimize adverse effects. Precision medicine has shown promising results in various medical fields, such as oncology, where targeted therapies can be designed to specifically combat cancer cells while sparing healthy tissue. It also has applications in areas like cardiology, neurology, and psychiatry, helping to optimize treatments for ailments ranging from heart disease to mental health disorders. Ultimately, precision medicine aims to revolutionize healthcare by delivering tailored, efficient, and patient-centered solutions that improve outcomes and quality of life.

Japan Precision Medicine Market Trends:

The precision medicine in Japan is rapidly gaining momentum in the healthcare industry. Several drivers are propelling its growth. Firstly, advancements in genomics and biotechnology have paved the way for a deeper understanding of the genetic basis of diseases. This knowledge has enabled the development of targeted therapies, leading to improved patient outcomes. Moreover, the increasing incidence of chronic diseases in Japan is a significant driver. Precision medicine offers the promise of more efficacious treatments and better disease management, potentially reducing the burden on healthcare systems. Additionally, government initiatives and funding support for precision medicine R&D are playing a pivotal role. Policymakers recognize the potential of precision medicine to reduce healthcare costs and improve patient care, leading to increased investments in this field. Apart from this, the inflating application of big data and advanced analytics tools with the integration of electronic health records, genomic data, and clinical information that allow for more precise diagnosis and treatment recommendations is expected to drive the precision medicine in Japan during the forecast period.

Japan Precision Medicine Market Segmentation:

Product Insights:

Consumables
Instruments
Services

Technology Insights:

Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics
Others

Application Insights:

Oncology
Central Nervous System (CNS)
Immunology
Respiratory Medicine
Infections
Others

End User Insights:

Hospitals and Clinics
Diagnostic Centers
Pharma and Biotech Companies
Healthcare IT Firms
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan precision medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan precision medicine market?
What is the breakup of the Japan precision medicine market on the basis of product?
What is the breakup of the Japan precision medicine market on the basis of technology?
What is the breakup of the Japan precision medicine market on the basis of application?
What is the breakup of the Japan precision medicine market on the basis of end user?
What are the various stages in the value chain of the Japan precision medicine market?
What are the key driving factors and challenges in the Japan precision medicine?
What is the structure of the Japan precision medicine market and who are the key players?
What is the degree of competition in the Japan precision medicine market?

Product Code: SR112025A15542

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Precision Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Precision Medicine Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Precision Medicine Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Precision Medicine Market - Breakup by Technology

7.1 Big Data Analytics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Bioinformatics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Gene Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Drug Discovery
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Companion Diagnostics
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Precision Medicine Market - Breakup by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Central Nervous System (CNS)
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Respiratory Medicine
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Infections
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 9.6.2 Market Forecast (2025-2033)

9 Japan Precision Medicine Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Centers
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Pharma and Biotech Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Healthcare IT Firms
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)

10 Japan Precision Medicine Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Precision Medicine Market - Industry Analysis

12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis